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A biofilm is an organized, resilient group of microbes
in which individual cells acquire properties, such as
drug resistance, that are distinct from those ob-
served in suspension cultures. Here, we describe
and analyze the transcriptional network controlling
biofilm formation in the pathogenic yeast Candida
albicans,whosebiofilmsareamajorsourceofmedical
device-associated infections. We have combined
genetic screens, genome-wide approaches, and two
in vivo animal models to describe a master circuit
controlling biofilm formation, composed of six tran-
scription regulators that form a tightly woven network
with 1,000 target genes. Evolutionary analysis indi-
cates that the biofilm network has rapidly evolved:
genes in the biofilm circuit are significantly weighted
toward genes that arose relatively recently with
ancient genes being underrepresented. This circuit
provides a framework for understanding many as-
pects of biofilm formation by C. albicans in a mam-
malian host. It also provides insights into how
complex cell behaviors can arise from the evolution
of transcription circuits.
INTRODUCTION
Biofilms are organized communities of surface-associated
micro-organisms embedded in a matrix of extracellular poly-
mers. In this paper, we analyze howC. albicans, the predominant
fungal pathogen of humans, forms biofilms. Biofilms are a
major microbial growth form in natural environments (Kolter
and Greenberg, 2006) and a leading cause of persistent human
infection (Costerton et al., 1999). These infections are typically
seeded from biofilms that form on implanted medical devices,126 Cell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc.such as intravascular catheters, and become resistant to
drug and mechanical treatments (Donlan and Costerton,
2002). The mechanisms behind biofilm development are thus
important to our understanding of microbial ecology (because
mixed species biofilms are common) as well as infectious
disease.
C. albicans biofilm formation can be partitioned into four
basic stages, based on studies carried out in vitro (Baillie and
Douglas, 1999; Chandra et al., 2001; Douglas, 2003; Hawser
and Douglas, 1994; Nobile et al., 2009; Uppuluri et al.,
2010a, 2010b). These are: (1) attachment and colonization of
yeast-form (nearly spherical) cells to a surface, (2) growth and
proliferation of yeast-form cells to allow formation of a basal
layer of anchoring microcolonies, (3) growth of pseudohyphae
(ellipsoid cells joined end to end) and extensive hyphae (chains
of cylindrical cells) concomitant with the production of ex-
tracellular matrix material, and (4) dispersal of yeast-form cells
from the biofilm to seed new sites. At least some of these
features of biofilm formation have also been observed in vivo.
For example, C. albicans biofilms from denture stomatitis
patients confirm the presence of yeast, hyphae, and extracel-
lular matrix (Ramage et al., 2004). Furthermore, biofilm archi-
tectures in two animal catheter models and a denture model
include numerous yeast cells in the basal region, as well as
hyphae and extracellular matrix extending throughout the
biofilm (Andes et al., 2004; Nett et al., 2010; Schinabeck
et al., 2004).
Here, we combine ‘‘classical’’ genetics, genome-wide
approaches, RNA deep sequencing technology, and two in vivo
animal models to comprehensively map the transcriptional
circuitry controlling biofilm formation in C. albicans. The circuit
has led to many new predictions about genes involved in
biofilm formation, and we have validated a set of these pre-
dictions by confirming the roles of several of these genes in
biofilm development. The circuit also provides insight into
how biofilm formation may have evolved in the C. albicans
lineage.
Figure 1. Screening and Characterization of In Vitro Biofilm-Defective Transcription Regulator Mutants
(A) Biofilm biomass (dry weight) determinations of the entire transcription regulator (TR) mutant library (165 strains). The average total biomass ± standard
deviation for each TR mutant strain grown under standard biofilm conditions (Experimental Procedures) was calculated from five independent samples of each
strain. Statistical significance (p values) was calculated with a Student’s one-tailed paired t test and is represented by the red asterisk under the nine regulator
strains (TF022, TF091, TF095, TF103, TF110, TF115, TF117, TF137, and TF156) with biomasses significantly deviating (p < 0.0005) from the reference strain
(SN250).
(B–O) Phenotypic characterization of the mutants compared to the wild-type.
(B–H) The visual appearance after 48 hr of growth on polystyrene plates.
(I–O) CSLM side view images of the wild-type and six biofilm-defective mutant strains.
Scale bars represent 20 mm. See also Table S1 and Figures S1, S2, and S3.RESULTS
Identification and Phenotypic Characterization of
Biofilm-Defective Transcription Regulator Mutants
In Vitro
Transcription regulators (defined here as sequence-specific
DNA-binding proteins that regulate transcription) play important
roles in the control of many developmental pathways; often, they
define a group of coregulated target genes that function together
to carry out a specific function in the cell. Hence, transcription
regulators represent a powerful entry point to understanding
a biological process. Using information on transcription regula-
tors taken from a wide variety of species, we constructed
a C. albicans library of 165 fully vetted transcription regulator
(TR) deletion mutants consisting of two independently con-
structed mutants for each strain (Homann et al., 2009). This
library was screened for biofilm formation on the surface of
serum-treated polystyrene plates under a standard set of bio-
film-inducing conditions (Nobile et al., 2006a, 2006b; Nobile
and Mitchell, 2005). The screening was based on biofilm dry
weight biomass, visual, and microscopic (confocal) inspection
(Figure 1). The screen revealed nine mutants with deficiencies
in forming biofilms (Figure 1A and Table S1 and Figure S2A avail-able online). Three of these mutants were not analyzed further
because they exhibited either general growth defects in suspen-
sion cultures or a wide variety of other phenotypes in suspension
cultures (Extended Experimental Procedures). The remaining six
transcription regulator deletion mutants (bcr1D/D, tec1D/D,
efg1D/D, ndt80D/D, rob1D/D, and brg1D/D) have the following
characteristics: (1) they were significantly compromised in bio-
film formation compared to the wild-type (p < 0.0005) (Figures
1B–1H), (2) they did not exhibit general growth defects, and (3)
they did not show extensive phenotypes aside from defects in
biofilm formation. Of these six transcription regulators, three
are newly identified as biofilm regulators (Ndt80/Orf19.2119,
Rob1/Orf19.4998 [named for regulator of biofilms], and Brg1/
Orf19.4056 [named for biofilm regulator]), and three had been
previously implicated in biofilm formation (Bcr1 [Nobile and
Mitchell, 2005], Tec1 [Nobile andMitchell, 2005], and Efg1 [Ram-
age et al., 2002]). The screen was carried out blindly, and our
identification of all previously identified regulators serves as an
internal control for both the library construction and the screen.
We further characterized the morphology of the six biofilm-
defective mutant strains compared to the wild-type by confocal
scanning lasermicroscopy (CSLM), using silicone squares as the
substrate (Figures 1I–1O). By CSLM, the wild-type referenceCell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc. 127
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Figure 2. Biofilm Formation in Two In Vivo Rat Models: A Catheter
Model and a Denture Model
(A–G) For the catheter model, the wild-type reference strain SN250 (A) and the
six transcription regulator mutant strains (panels B–G) were inoculated into rat
intravenous catheters; resulting biofilms were visualized after 24 hr of growth
by scanning electron microscopy (SEM). SEM catheter images show the
catheter luminal surfaces at magnifications of 1,0003.
(H–N) For the denture model, the wild-type reference strain SN425 (H) and the
six transcription regulator mutant strains (I–N) were inoculated into rat
dentures, and the resulting biofilms were visualized after 24 hr of growth by
SEM. SEM denture images show the denture surfaces at magnifications of
2,0003.
See also Figure S4.strain formed a biofilm with typical architecture and thickness
(Chandra et al., 2001; Douglas, 2003; Nobile and Mitchell,
2005) of 250 mm in depth, containing both round budding
yeast-form cells adjacent to the substrate and hyphal cells ex-
tending throughout the biofilm (Figure 1I) (see also Figure S1
for CSLM visualization of each regulator mutant over a time
course of biofilm development). In all six mutants, only rudimen-
tary biofilms of 20–80 mm in depth were formed, although the
detailed phenotypes of the mutants differ (Figures 1J–1O and
S1). Reintroduction of an ectopic copy of the wild-type allele
back into each mutant reversed the biofilm formation defect of
each mutant (Figure S2B). Thus, BCR1, TEC1, EFG1, NDT80,
ROB1, and BRG1 are required for wild-type biofilm formation
in vitro.
Because hyphal development is an important step in normal
biofilm development, we assessed the ability of our six biofilm-
defective transcription regulator mutants to form normal hyphae
when they were not in the context of a biofilm. We found that,
with the exception of the efg1D/D strain, true hyphae could be
detected in the medium surrounding the biofilm (Figure S3A) as
well as in suspension cultures using the same medium as that
used for biofilm formation (Figure S3B).We also observed hyphal
development for all strains except the efg1D/D strain in a variety
of suspension culturemedia, although the fraction of hyphal cells
was often reduced relative to the parental strain (Figure S3B).
Thus, for all of these mutants (with the possible exception of
efg1D/D), the defect in biofilm formation was not due to an
intrinsic inability to form hyphae.
Characterization of Biofilm-Defective Transcription
Regulator Mutants in Two In Vivo Animal Models
Biofilm formation in vivo is the cause of the majority of new infec-
tions in humans, and it is widely appreciated that the conditions
for biofilm formation in vivo differ considerably from those in stan-
dard in vitro assays (Nett and Andes, 2006). For example, many
additional elements are present in vivo, such as liquid flow, host
factors, and components of the host immune response. Because
biofilm-based catheter infections are a major clinical problem
(Kojic and Darouiche, 2004), we used a well-established rat
venous catheter model of infection (Andes et al., 2004) to test
the six mutants for biofilm formation in vivo. We inoculated the
catheters with C. albicans cells intraluminally, allowed biofilm
formation to proceed for 24 hr, removed the catheters, and visu-
alized the catheter luminal surfaces by scanning electronmicros-
copy (SEM) (Figures 2A–2G and S4A). The wild-type reference
strain formed a thick, mature biofilm on the rat catheter, consist-
ing of yeast and hyphal cells and extracellular matrix material
(Figure 2A). Of the six transcription regulator mutants, five
(bcr1D/D, tec1D/D, efg1D/D, ndt80D/D, and rob1D/D) were
unable to formbiofilms (Figures 2B–2F); bcr1D/D had been previ-
ously shown to bedefective in thismodel (Nobile et al., 2008). The
sixth mutant (brg1D/D) formed a thick biofilm consisting of
many adherent cells and a large amount of extracellular matrix
material (Figure 2G) but appeared morphologically distinct from
the reference strain in that considerably fewer hyphae were
observed within the biofilm (compare Figures 2A and 2G).
The most common form of oral candidiasis is denture stoma-
titis, prevalent largely in the elderly population, and affecting up128 Cell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc.to 70% of denture wearers (Webb et al., 1998; Wilson, 1998).
Denture stomatitis occurs by biofilm colonization and growth
over the surface of a denture, leading to inflammation of the
palatal mucosa (Ramage et al., 2004). Because biofilm growth
on dentures represents a completely different host environment
from that of an intravenous catheter, we also screened our six
biofilm-defective regulator mutants in a recently established
in vivo rat denture model, which was developed to mimic and
assess C. albicans biofilm formation in denture stomatitis (Nett
et al., 2010). In particular, this oral model includes host salivary
components, host commensal bacteria, salivary flow dynamics,
and direct contact between the denture biofilm and the host
mucosal surface (Nett and Andes, 2006). We inoculated the rat
dentures with C. albicans cells, permitted biofilm formation to
proceed for 24 hr, removed the dentures, and visualized the
denture surfaces by SEM (Figures 2H–2N). The wild-type refer-
ence strain formed a thick, mature biofilm on the surface of the
rat denture, consisting predominantly of hyphal C. albicans cells
interspersed with C. albicans yeast-form cells, various host
commensal oral bacteria, and extracellular matrix material (Fig-
ure 2H). In contrast, the genetically matched mutant strains all
showed significant defects in biofilm formation. In particular,
tec1D/D, efg1D/D, ndt80D/D, rob1D/D, and brg1D/D were
severely defective (Figures 2J–2N), whereas the bcr1D/D
mutant, which has previously been shown to be defective in
this model (Nett et al., 2010), had less pronounced defects
than the other five mutants (Figure 2I). We note that extensive
bacterial biofilms consisting of both cocci and rods were seen
on the dentures of the six C. albicans biofilm-defective mutants
(Figure S4B), suggesting a competition between biofilm forma-
tion by C. albicans and biofilm formation by the native bacteria
present in the mouth.
In summary, BCR1, TEC1, EFG1, NDT80, ROB1, and BRG1
are each required for normal biofilm formation in vivo in both
the rat denture and catheter models. The effects of certain dele-
tion mutants (brg1D/D and bcr1D/D) differed to varying degrees
between the two models (compare Figures 2G with 2N and 2B
with 2I), likely reflecting the influence of the host environment
in biofilm formation. The results, taken as a whole, indicate that
performing genetic screens and analyzing biofilm formation
in vitro is a valid approach to understanding clinically relevant
C. albicans biofilm formation.
Developing Transcriptional Relationships among
Biofilm Regulators
To identify genes directly regulated by Bcr1, Tec1, Efg1, Ndt80,
Rob1, and Brg1, we performed full-genome chromatin immu-
noprecipitation microarray (ChIP-chip) to map the position
across the genome to which each of the six transcription regula-
tors is bound during biofilm formation. Based on this analysis
(see Extended Experimental Procedures for details, Tables
S2A–S2F for a complete list of all significantly bound locations
for each regulator, and Data S1 for MochiView image plots of
every called significant peak for each regulator), we calculate
the following number of intergenic regions bound by each regu-
lator: 211 for Bcr1, 76 for Tec1, 328 for Efg1, 558 for Ndt80, 95 for
Rob1, and 283 for Brg1 (Table S2G). 831 intergenic regions are
bound by one or more regulators, 350 intergenic regions are
bound by two or more, 186 intergenic regions are bound by three
or more, 111 intergenic regions are bound by four or more,
55 intergenic regions are bound by five or more, and 18 inter-
genic regions are bound by all six of the biofilm regulators(Table S2G). We noticed two unusual characteristics for the in-
tergenic regions bound by the biofilm regulators. First, the
average length of intergenic regions bound by the biofilm regula-
tors is more than twice that of the remainder of the genome
(1540 bp compared with 693 bp); this trend is true for all six bio-
film regulators (Table S4F). Second, binding peaks are distrib-
uted throughout the intergenic regions of the regulator-bound
target genes rather than being clustered a fixed distance
upstream of the transcription start site (Data S2), as is common
for many yeast target genes (Lin et al., 2010).
If we convert bound intergenic regions to genes likely to
be controlled (for example, a single bound intergenic region
between divergently transcribed genes is counted as two
genes), our analysis suggests that the network is composed
of 1,061 target genes that are bound in their promoter regions
by at least one of the six biofilm regulators (Figure 3 and
Table S3A). This regulatory network is shown in Figure 3. Based
on the ChIP-chip data, the high degree of overlap between target
genes among biofilm regulators suggests that the biofilm regula-
tory network is considerably interwoven; that is, many of the
target genes are controlled by more than one regulator.
The results also indicate that the six regulators originally iden-
tified in the genetic screen control each other’s expression: all six
of the regulators bind to the upstream promoter regions of BCR1
(Figure 4A), TEC1 (Figure 4B), EFG1 (Figure 4C), and BRG1 (Fig-
ure 4F); four of the regulators (Tec1, Efg1, Ndt80, and Rob1) bind
to the upstream promoter region of ROB1 (Figure 4E); and two of
the regulators (Efg1 and Ndt80) bind to the upstream promoter
region of NDT80 (Figure 4D).
De Novo Motif Finding for the Six Master Biofilm
Regulators
A test of the self-consistency of ChIP-chip data is the nonrandom
occurrence of cis-regulatory sequences (motifs). Based on
several hundred significant binding events from our ChIP-chip
data, we were able to identify statistically significant motifs for
all six of the biofilm regulators (Figure 4G, Data S2, and Tables
S2H–S2M). This motif generation was based solely on the ChIP-
chip data and did not incorporate data fromany other experiment
or from any other species. We note that the motif generated for
Ndt80 (TTACACAAAA) is very similar to the reported binding
motif for its homolog, Ndt80, in S. cerevisiae (GMCACAAAA)
(Zhu et al., 2009). The motif for Tec1 (RCATTCY) is identical to
that determined for its homolog, Tec1, in S. cerevisiae (Harbison
et al., 2004;Madhani and Fink, 1997). (This Tec1motif, generated
from 107 bound intergenic regions, does not closely resemble
the Tec1motif recently reported in the white-specific pheromone
response element [WPRE] [AAAAAAAAAAGAAAG] inC. albicans,
whichwasgenerated fromamuchsmaller set of data [Sahni et al.,
2010].) Finally, the Efg1 motif derived from our ChIP-chip data
(RTGCATRW) closely resembles the TGCAGNNA consensus
sequence of the S. cerevisiae ortholog, Sok2 (Harbison et al.,
2004). Thus, for three of the biofilm regulators, the motifs devel-
oped from our C. albicans ChIP-chip data can be independently
verified by their similarities to the motifs recognized by their
S. cerevisiae orthologs. This analysis provides independent
support for both the motif analysis and for the validity of the full-
genome ChIP data. For the other three regulators, we were ableCell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc. 129
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Figure 3. The Biofilm Regulatory Network
(A and B) The six master biofilm regulators are represented by the six large circular hubs. Smaller circles represent target genes, which are connected to their
respective regulators by dashed lines, indicating a direct interaction as determined by genome-wide ChIP-chip. Genes that are differentially regulated as
determined by expression data (using a 2-fold cutoff) in biofilm compared to planktonic cells are shown in blue for those genes upregulated in biofilms, in yellow
for those downregulated, and in gray for those with no change. Gray boxes are drawn around the 23 target genes bound by all six regulators and are connected to
their respective regulators by red dashed lines (A). The identity of these 23 genes are indicated as the colored ovals in (B) (blue ovals are genes that are upre-
gulated, yellow ovals are genes that are downregulated, and gray ovals are genes with no change in biofilm compared to planktonic cells). Overall, 23 genes are
bound by all six, 77 are bound by five or more, 165 are bound by four or more, 265 are bound by three or more, and 458 are bound by two or more of the biofilm
regulators. See also Table S3A.to determine statistically significant motifs, but we were not able
to independently verify them by comparison with S. cerevisiae
because either the orthology relationships are uncertain (Rob1
and Brg1) or the orthologous S. cerevisiae regulator has not
been characterized (Bcr1).130 Cell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc.Exploring the Transcriptional Patterns of Biofilms
Although the ChIP-chip experiments reveal the genomic posi-
tions where each regulator binds, they do not indicate whether
these binding events are associated with differences in gene
transcription. We first consider control of the regulators
Figure 4. Chromatin Immunoprecipitation Map-
ping and Motif Identification of the Six Master
Biofilm Regulators and Evolutionary Analysis of
the Biofilm Target Genes
(A–G) All six regulators bind to each another’s upstream
promoter regions (A–F). Immunoprecipitation (IP) binding
data for Bcr1-Myc (orange line), Tec1-custom antibody
(light blue line), Efg1-Myc (magenta line), Ndt80-Myc (dark
blue line), Rob1-Myc (red line), Brg1-Myc (green line),
untagged wild-type/control IP (gray line), and tec1D/D
(yellow line) strains are shown. The ChIP-chip microarray
binding data was mapped and plotted onto the chromo-
somes containing BCR1 (A), TEC1 (B), EFG1 (C), NDT80
(D), ROB1 (E), and BRG1 (F) using MochiView. The pro-
moters of these genes show significant peak enrichments
for the binding of the indicated biofilm regulators. The
x axis represents ORF chromosomal locations. The y axis
gives the Agilent normalized enrichment value (log2)
postsmoothing for the binding of each regulator. Genes
(pink boxes) plotted above the bold line read in the sense
direction; genes plotted below the bold line read in the
antisense direction. Using de novo motif finding based on
our ChIP-chip data, we identified significantly enriched
core binding motifs for all six biofilm regulators (G). Motifs
were identified using MochiView and independently veri-
fied using MEME, and motif graphics were generated with
MochiView. Colored stars corresponding to the colors of
the regulators indicate the location of strong instances of
the indicated biofilm regulator motifs under the enrich-
ment peaks in A–F.
(H) The evolutionary age of target genes in the biofilm
network. Genes were divided into three categories based
on when they arose during evolution, with the numbers in
each bar giving the number of C. albicans genes that fall
into that age category (based on the union of RNA-seq and
microarray data sets for biofilm versus planktonic cells).
The enrichment of each age category in biofilm-regulated
genes is log10 of the observed divided by the expected (for
all age categories, p < 1.23 3 109).
(I) A histogram of the length of the intergenic regions
between tandem and divergent gene pairs targeted by the
biofilm regulators. Each category was normalized to the
total number of intergenic regions in that category.
See also Data S1 and S2 and Tables S2, S3, S4, and S5.themselves, as they are all bound by one or more of the other
regulators. We deleted each regulator and measured the
mRNA levels of the other five (Figure S7A). This analysis revealed
that each regulator positively regulates each of the other regula-
tors. We also examined the effect of each regulator on its own
synthesis by fusing its upstream region to an mCherry reporter
and measuring levels of the reporter in the absence and pres-
ence of the regulator (Figure S7B). In all cases, a given regulator
activates its own synthesis. Thus, the connections among the six
biofilm regulators are primarily, if not exclusively, positive.
To assess the relationship of regulator binding and transcrip-
tion across the entire circuit, we performed both RNA-seq and
gene expression microarray analyses of cells grown in biofilm
and planktonic conditions. From our RNA-seq data, we gener-
ated 46 million mappable strand-specific sequence reads, ex-
panding our previous gene annotation (Tuch et al., 2010) by iden-
tifying 622 ‘‘novel transcriptionally active regions’’ (nTARs) and
161 nTARs that overlap, at least partially, transcribed regions
identified in other recent genome-wide experimental annotations(Bruno et al., 2010; Sellam et al., 2010) (Table S4A). We know
from previous work that nTARs identified by RNA-seq include
both noncoding RNAs (Mitrovich et al., 2010) and transcripts
that encode for proteins too short to have been identified in
previous genome annotations (Tuch et al., 2010).
We used our RNA-seq data in addition to our gene expression
microarray data to obtain a complete set of genes (coding and
noncoding) differentially expressed between planktonic and bio-
film conditions (Table S4). Combining the RNA-seq and microar-
ray data, we find 1,599 genes upregulated and 636 genes
downregulated at least 2-fold in biofilm compared to planktonic
cells (Tables S4B and S4C, respectively). By analyzing the over-
lap between our ChIP-chip data and our gene expression data
(Table S5), we find a strong correlation between transcription
regulator binding and differential gene expression. For example,
if we consider regions bound by at least four transcription regu-
lators, 60% of these regions are associated with differentially
expressed transcripts. This is significantly greater than that ex-
pected by chance (p < 0.0001) and suggests, at least broadly,Cell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc. 131
that binding of the regulators is associated with differential tran-
scription in biofilm versus planktonic cultures. For the correlation
between the binding of a given single transcription regulator and
differential gene expression, we find a range of 38%–56%,
comparable to or greater than the associations documented
for other C. albicans transcription regulators (Askew et al.,
2011; Lavoie et al., 2010; Nobile et al., 2009; Sellam et al.,
2009; Tuch et al., 2010).
We examined the evolutionary history of genes that are
differentially regulated under biofilm conditions. To do this, we
categorized each C. albicans gene into an age group based
on orthology mappings across the Ascomycota, a large
group of yeasts that includes both C. albicans and S. cerevisiae
(Wapinski et al., 2007) (Extended Experimental Procedures).
Gene ages were defined using orthology assignments from The
Fungal Orthogroups Repository (http://www.broad.mit.edu/
regev/orthogroups/). The oldest genes are present in distantly
related yeast clades, whereas the youngest are found only in
C. albicans. Young genes can arise in several ways, including
relatively rapid mutation that obscures the relation to an ancient
gene, horizontal gene transfer, and de novo gene formation
(Long et al., 2003). We found that genes upregulated in biofilms
are enriched for young andmiddle-aged genes and are depleted
in old genes. The opposite trend was observed for genes that are
downregulated in biofilms (Figure 4H). Genes that were not differ-
entially expressed were not strongly enriched for any age cate-
gory (Table S4E). Young genes typically show longer intergenic
regions than old genes (Sugino and Innan, 2011), and this trend
may help to explain the unusually long intergenic regions of
biofilm circuit genes. However, biofilm genes exhibited sig-
nificantly longer intergenic regions evenwhen compared to other
young genes (p < 2.2 3 1016) (Figure 4I).
Identifying Functionally Relevant Target Genes
of the Master Biofilm Network
To understand the connections between the six regulators and
biofilm development, we performed gene expression microarray
experiments of all six regulator mutants compared to a reference
strain under biofilm-forming conditions. In interpreting this
data, it is important to keep in mind that the mutant strains do
not form mature biofilms under these conditions, so many of
the transcriptional effects may be indirect consequences of
defective biofilms. Consistent with this idea, the transcriptional
responses to deletion of each of the biofilm transcription regula-
tors tended to encompass a relatively large set of genes (Table
S3A). For example,we found234genes thatwere downregulated
and 173 genes that were upregulated in the bcr1D/D mutant
relative to the isogenic parent (threshold of [log2 > 0.58 and
log2 < 0.58]) (Table S3C). Of these genes, Bcr1 binds directly
to the promoters of 46 (11%) of them, a number that is signifi-
cantly higher than that predicted by chance (p = 0.0002). None-
theless, the results indicate that most of the effects of deleting
Bcr1 are indirect. Of the genes directly bound by Bcr1, half
were downregulated and half were upregulated in the bcr1D/D
mutant, indicating that Bcr1 can act as both an activator and
repressor of its direct target genes. Similar analysis (Table S3C
and Extended Experimental Procedures) indicates that Efg1,
Ndt80, Rob1, and Brg1 are all both activators and repressors of132 Cell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc.their biofilm-relevant direct target genes and that Tec1 isprimarily
an activator of its biofilm-relevant direct target genes.
From these large data sets, we attempted to identify a set of
target genes that might be expected to have important roles in
biofilm formation. Using hierarchical cluster analysis to charac-
terize genes with similar patterns of expression in each of the
six biofilm regulator mutants compared to a reference strain
under biofilm conditions, we found 19 target genes that were
differentially regulated in all six data sets (threshold of [log2 >
0.58, and log2 <0.58]) (Figure 5A and Table S3A). Eight of these
target genes (ORF19.3337, ALS1, TPO4, ORF19.4000, EHT1,
HYR1, HWP1, and CAN2) were expressed at lower levels in all
six of the biofilm regulator mutants compared to the reference
strain (Figure 5A); seven of these genes were also expressed
at higher levels in biofilm compared to planktonic wild-type cells
(Table S3A). Additionally, all of these eight target genes were
bound in their upstream promoter regions by at least one of
the six biofilm regulators; most were bound by multiple regula-
tors (Figures 5B–5I).
Further analysis of the regulation of these eight target genes
helps to reconcile their expression patterns with the chromatin
IP results. As indicated in Figure S5, the transcriptional effects
of deleting each one of the six regulators can be accounted for
by: (1) direct binding and transcriptional activation by that
regulator on the target gene and/or (2) direct binding and activa-
tion of a different regulator that, in turn, binds directly to and acti-
vates the target gene (Figure S5). This ‘‘hierarchical cascade’’
between the biofilm regulators and target genes, applied more
broadly, can explain much of the expression data (Figure S5,
Tables S3A and S3C, and Extended Experimental Procedures).
To determine whether the eight target genes identified by this
analysis affected biofilm formation, we constructed homozygous
deletion strains for each of the eight target genes. We observed
significant biofilm defects for als1D/D (p = 0.01), hwp1D/D
(p = 0.01), and can2D/D (p = 0.003) mutant strains compared
to the reference strain, with the can2D/D strain the most defec-
tive (Figure 6A). Although all three of thesemutants were capable
of forming partial biofilms, these biofilms were less stable than
those of the wild-type and often detached from the substrate;
partial biofilm defects have been previously reported for als1D/D
and hwp1D/Dmutant strains (Nobile et al., 2006a, 2006b; Nobile
et al., 2008), whereas can2D/D is new to this study. The other five
knockout strains did not show any obvious biofilm defects under
the conditions tested, and we hypothesized that their roles may
be masked by genetic redundancy. To explore this idea, we
created ectopic expression strains in which each of the eight
target genes was ectopically expressed in strains in which
each transcription regulator was deleted. In other words, in
a grid of 63 8 = 48 constructed strains, we determined whether
ectopic expression of the target genes could suppress the
defect of the original transcription regulator deletion. Overex-
pression of several of the candidate target genes was able
to significantly rescue biofilm formation to varying degrees
depending on the target gene mutant background combination
(p < 0.0005) (Figure 6B; see Figure S6 for CSLM images
of the rescued biofilms). For example, overexpression of
ORF19.4000,CAN2, or EHT1 in the bcr1D/Dmutant strain back-
ground was able to rescue biofilm formation to near wild-type
Figure 5. Core Candidate Biofilm Target Genes
(A) Using hierarchical cluster analysis of our gene expressionmicroarray data, we identified a set of 19 candidate target genes (IHD1,PGA54, FAV2,ORF19.3337,
ALS1, TPO4, ORF19.4000, EHT1, HYR1, HWP1, CAN2/ORF19.111, IDP2,MDH1, PCK1, PGK1, AOX2, ORF19.4653, ORF19.4080, and ORF19.2220) that were
differentially regulated (log2 > 0.58, and log2 <0.58) in all gene expression array experiments that compared each biofilm regulator mutant to a reference strain
under biofilm conditions (A). Eight of these targets were differentially regulated in the same direction (all down in the mutants) and were chosen for further
functional analyses (A, as indicated by the blue square).
(B–I) ChIP-chip enrichment data for the binding of the six biofilm regulators in the promoters of these eight candidate target genes. IP binding data for Bcr1-Myc
(orange line), Tec1 custom antibody (light blue line), Efg1-Myc (magenta line), Ndt80-Myc (dark blue line), Rob1-Myc (red line), Brg1-Myc (green line), untagged
wild-type/control IP (gray line), and tec1D/D (yellow line) strains are shown. The ChIP-chip microarray binding data were mapped and plotted onto the chro-
mosomes containingORF19.3337 (B),ALS1 (C), TPO4 (D),ORF19.4000 (E), EHT1 (F),HYR1 (G),HWP1 (H), andCAN2 (I) usingMochiView. The promoters of these
genes show significant peak enrichments for the binding of the indicated biofilm regulators:ORF19.3337 byBcr1, Efg1, Ndt80, and Rob1 (B);ALS1 byBcr1, Tec1,
Efg1, Ndt80, and Brg1 (C); TPO4 by Tec1 and Ndt80 (D); ORF19.4000 by Bcr1, Tec1, Efg1, Ndt80, and Brg1 (E); EHT1 by Ndt80 (F); HYR1 by Efg1 (G); HWP1 by
Ndt80 (H); andCAN2 by Efg1 (I). The x axis represents ORF chromosomal locations. The y axis is the Agilent normalized enrichment value (log2) postsmoothing for
the binding of each regulator. Genes (pink boxes) plotted above the bold line read in the sense direction; genes plotted below the bold line read in the antisense
direction. Colored stars corresponding to the colors of the regulators indicate the location of strong instances of the indicated biofilm regulator motifs under the
enrichment peaks.
See also Figure S5 and Table S3.
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Figure 6. Functionally Relevant Biofilm Target Genes
(A and B) Biofilm biomass (dry weight) determinations were measured for the
eight core candidate biofilm target gene deletion mutants (A) and the strains in
which each of the eight target genes was ectopically expressed in the back-
ground of each regulator mutant (B). The average total biomass ± standard
deviation for each strain grown under standard biofilm conditions was calcu-
lated from five independent samples of each strain. Statistical significance
(p values) was calculated with a Student’s one-tailed paired t test and is rep-
resented by the red asterisks above the strains with biomasses significantly
deviating (p < 0.0005) from either the reference strain (WT) for (A) or the cor-
responding mutant strain for (B). See also Figure S6 and Table S3.levels of biomass (although the biofilms are fragile) (Figure 6B
and Figure S6), implicating these genes in biofilm formation.
Taken as a whole, our data suggest that six of the original set
of eight candidate target genes have direct roles in biofilm forma-
tion. Of course, there are more than 1,000 additional target
genes, and their analysis is a future challenge.
DISCUSSION
A Master Transcription Network Controlling Biofilm
Formation in C. albicans
We have described a master circuit of six transcription regula-
tors that controls biofilm formation by C. albicans in vitro and
in two different animal models. C. albicans biofilms are an orga-
nized structure of three types of cells (yeast, pseudohyphae, and
hyphae) enclosed in an extracellular matrix. The transcription
regulators form an elaborate, interconnected transcriptional
network: each regulator controls the other five, and most target
genes are controlled by more than one master regulator (Fig-
ure 3). The circuit appears to be based largely, if not exclusively,
on positive regulation (Figures 7, S7A, and S7B). Taking into134 Cell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc.consideration all of the target genes of the six regulators, the
biofilm network comprises about 15% of the genes in the
genome.
Circuit Complexity
Although the circuit is large and complex (1,000 genes and
twice that many connections), this level of complexity is not
without precedent. For example, circuits that control osmotic
stress and pseudohyphal growth pathways of S. cerevisiae (Bor-
neman et al., 2006; Ni et al., 2009), competence and spore
formation in Bacillus subtilis (de Hoon et al., 2010; Hamoen
et al., 2003; Losick and Stragier, 1992; Su¨el et al., 2006), the
hematopoietic and embryonic stem cell differentiation pathways
of mammals (Wilson et al., 2010; Young, 2011), and the regula-
tion of circadian clock rhythms in Arabidopsis thaliana (Alabadı´
et al., 2001; Locke et al., 2005) show certain similarities: they
all consist of a core group of master transcription regulators
that control each other and—working together—control a large
set of additional target genes.
Several possibilities might account for the complexity of the
biofilm network. The regulators we have described can orches-
trate biofilm formation in two very different niches of the human
host: the bloodstream and the oral cavity. It seems likely that
the same circuit also controls biofilm formation in other host
niches (for example, in the vagina and gastrointestinal tract).
Thus, the biofilm circuit responds to many environmental condi-
tions, such as temperature, nutrient availability, flow rate, sur-
face type, other microbial species, and components of the
host immune system. One possibility is that the complex circuit
that we have described can integrate a wide range of environ-
mental cues to produce a stereotyped morphological and func-
tional output under many different conditions. Consistent with
this idea is the finding that one regulator (Bcr1) plays an impor-
tant role in biofilm formation in the catheter model but has
a less pronounced role in the denture model, whereas another
regulator (Brg1) shows the opposite behavior. It is also possible
that the complex structure of the network (consisting of many
direct and indirect feedback loops, many feed-forward loops,
and highly overlapping regulons) is responsible for a form of
cell memory that acts over generations to ensure coordinated
cooperation among cells in maintaining the biofilm state. A third
possibility, as has been suggested for ribosomal protein gene
regulation (Mu¨ller and Stelling, 2009), is that the more complex
the regulatory architecture of a network, the more precisely the
dynamics of gene expression can be regulated.
A consideration of the evolution of the biofilm network might
also help to explain why it differs structurally from simple regula-
tory schemes. Incorporation of genes one at a time into a network
requires a gain of a binding site upstream of each gene; however,
bringing a regulatory protein gene into a network instantly incor-
porates all of that regulator’s targets into the network. Thus, the
interconnectedness of the biofilm network may reflect the ease
by which many genes can be simultaneously incorporated into
an existing circuit. Finally, it is formally possible that the com-
plexity per se of a transcriptional network is not, in itself, adap-
tive; rather, some aspects of the network complexity could
simply be the result of neutral (nonadaptive) evolution (Ferna´n-
dez and Lynch, 2011).
Figure 7. Regulatory Network Model for Biofilm
Formation
The biofilm network model based on our ChIP-chip and
expression data is shown. Solid arrows indicate direct
binding interactions determined by our ChIP-chip anal-
ysis. Solid black arrows indicate experimentally validated
regulatory interactions (as determined by expression
profiling data and validated by qPCR) in addition to direct
binding interactions (as determined by ChIP-chip data),
and solid gray arrows indicate direct binding interactions
only. The dashed black arrow indicates an indirect
regulatory interaction only. See also Table S3 and
Figure S7.Evolutionary Conservation of the Biofilm Network
Only a few of the many (probably more than a million) fungal
species can proliferate and cause disease in humans. These
pathogenic species are widely distributed over the fungal
lineage, indicating that survival in a human host probably
evolved independently multiple times. Although many fungal
species can form aggregates (flocs, mats, biofilms, etc.), it
seems likely that C. albicans is one of very few fungal species
that can efficiently form biofilms in a healthy mammalian host.
How then did the biofilm circuit evolve in the C. albicans
lineage?
Several lines of evidence suggest that the biofilm network in
C. albicans has undergone extensive evolutionary change rela-
tively recently. First, as described in the Results, ‘‘young’’ genes
are enriched in the biofilm circuit and ‘‘old’’ genes are underrep-
resented (Figure 4H). For example, 120 C. albicans genes
appear to have arisen (or at least have changed extensively) after
the common ancestor of C. albicans and Candida tropicalis
(a closely related species), and one-third of these are part of
the biofilm circuit. Second, if we map (when possible) the
C. albicans biofilm circuit target genes to other species, we
find the motifs of two of the master regulatory proteins (Ndt80
and Efg1) only sporadically enriched in these genes (Figure S7C).
Thus, the regulator-target gene connections are not strongly
conserved outside of C. albicans itself. (This analysis could not
be meaningfully performed for the other regulators due to a
lack of predictive power of their motifs [see Extended Experi-
mental Procedures]). Third, the intergenic regions targeted by
biofilm regulators are much longer than average (Figure 4I),
possibly providing a larger mutational target for the gain of
binding sites. In combination with short motifs, this may help to
explain how new genes have quickly become incorporated into
the network. Finally, as we discuss in greater detail below, the
functions of the master transcription regulators in C. albicansCell 148, 12have diverged significantly from their ‘‘assign-
ments’’ in S. cerevisiae. Our data and analyses
suggest that the biofilm networks of other CTG
clade species (species that translate the CUG
codon into serine instead of the conventional
leucine, e.g., C. tropicalis,Candida parapsilosis,
Lodderomyces elongisporus, Debaryomyces
hansenii, Candida guiermondii, and Candidalusitaniae) will likely be comprised of different transcription regu-
lators and/or different target genes, or both.
Evolutionary Reassignment of Transcription Regulators
A direct comparison between C. albicans and its nonpathogenic
relative S. cerevisiae provides additional insight into how the
biofilm network evolved. We can ask, for example, whether
the six master transcription regulators of biofilm formation in
C. albicans have clear orthologs in S. cerevisiae and, if so,
what processes they regulate in S. cerevisiae. To explore orthol-
ogy relationships for the master biofilm regulators, we used
SYNERGY and INPARANOID mappings, in addition to hand
annotation using constructed gene trees. Details are given in
Extended Experimental Procedures.
Overall, this analysis indicates that the biofilm circuit consists
of two regulators (Tec1 and Efg1) whose broad function—
regulation of cell morphology—is deeply conserved in the fungal
lineage. However, the set of target genes controlled by these
regulators differs significantly between S. cerevisiae and
C. albicans (Extended Experimental Procedures). A third regu-
lator (Ndt80) is deeply conserved in the fungal lineage, but its
function appears completely different between S. cerevisiae
and C. albicans. In the former, it regulates meiosis (Hepworth
et al., 1998) and, in the latter, biofilm formation. Two regulators
(Rob1 and Brg1) are detectable only in species closely related
toC. albicans, and the sixth biofilm regulator (Bcr1) has orthologs
in S. cerevisiae, but they have not been characterized. Given that
the DNA binding specificity of Tec1, Efg1, and Ndt80 is strongly
conserved, extensive gains and losses of cis-regulatory se-
quence must be responsible, at least in part, for the evolution
of the biofilm circuit in the C. albicans lineage. The Rob1 and
Brg1 proteins appear to have undergone extensive changes in
the C. albicans lineage such that their direct connection to the
ancestor of C. albicans and S. cerevisiae (if any) has been6–138, January 20, 2012 ª2012 Elsevier Inc. 135
obscured. Thus, it seems likely that extensive changes in both
regulators and cis-regulatory sequences were necessary for
the evolution of the modern C. albicans biofilm circuit. These
considerations, in combination with our analysis of ‘‘young’’
versus ‘‘old’’ genes, indicate that the C. albicans biofilm circuit
evolved relatively recently, and we suggest that this develop-
ment had an important role in the ability of C. albicans to adapt
to its human host.
EXPERIMENTAL PROCEDURES
Strain Construction
Primer sequences (Table S7) and C. albicans strains (Table S6) are described
in the Extended Experimental Procedures; strains were constructed in
isogenic backgrounds.
In Vitro Biofilm Growth, Confocal Microscopy, and Biomass
Determination
In vitro biofilm growth assays were carried out in Spider medium as described
in detail in the Extended Experimental Procedures. The average total biomass
for each strain was calculated from five independent samples. Statistical
significance (p values) was calculated with a Student’s one-tailed paired t test.
In Vivo Rat Catheter Biofilm Model
A rat central-venous catheter infection model (Andes et al., 2004) was used for
in vivo biofilm modeling to mimic human catheter infections, as described in
detail in the Extended Experimental Procedures. Catheters were removed
after 24 hr of C. albicans infection to assay biofilm development on the intra-
luminal surface by scanning electron microscopy (SEM).
In Vivo Rat Denture Biofilm Model
A rat denture stomatitis infection model (Nett et al., 2010) was used for in vivo
biofilmmodeling to mimic human denture infections, as described in Nett et al.
(2010), with certain modifications described in the Extended Experimental
Procedures. Dentures were removed after 24 hr post C. albicans infection to
assay biofilm development on the denture surface by SEM.
RNA Sample Preparation and Extraction
Details on growth, cell harvesting, RNA extraction, and treatment of biofilm
and planktonic cells used for gene expression microarray and RNA-seq anal-
ysis are described in the Extended Experimental Procedures.
Gene Expression Microarray Design and Analysis
We used custom-designed C. albicans oligonucleotide microarrays (AMADID
#020166) and a cutoff of 2-fold in both directions (log2 > 1.0 and log2 < 1.0) for
the differential expression of biofilm versus planktonic cells and 1.5-fold in
both directions (log2 > 0.58 and log2 < 0.58) for the differential expression
of mutant over wild-type (Extended Experimental Procedures and Table S3A).
Full-Genome Chromatin Immunoprecipitation Tiling Microarray
Each transcription regulator was tagged with a Myc tag at the C- or N-terminal
end of the protein in a wild-type reference strain background. (In the case of
Tec1, tagging the protein at either the C- or N- terminal end interfered with
the protein’s activity, and we used a custom-designed polyclonal antibody
against an epitope near the C terminus of the Tec1 protein.) The tagged strains
were grown under standard biofilm conditions (because the tags do not
compromise function, the strains form normal biofilms) and were harvested
for chromatin immunoprecipitation. After precipitation using the commercially
available Myc antibody or the custom Tec1 antibody, the immunoprecipitated
DNA and whole-cell extract were amplified and competitively hybridized to
custom whole-genome oligonucleotide tiling microarrays (AMADID #016350)
as described in the Extended Experimental Procedures. Display, analysis,
and identification of the binding events were determined using MochiView
(Homann and Johnson, 2010).136 Cell 148, 126–138, January 20, 2012 ª2012 Elsevier Inc.Motif Analysis
Motif analysis was performed using MochiView. MEMEwas also used to inde-
pendently verify motifs found by MochiView. See Data S2, Tables S2H–S2M,
and the Extended Experimental Procedures for details.
RNA Sequencing of Biofilm and Planktonic Cells
Strand-specific, massively parallel SOLiD System sequencing of RNA from
wild-type C. albicans biofilm and planktonic cells and mapping of resulting
reads were performed as previously described (Tuch et al., 2010). Library
amplification and sequencing resulted in 18 million planktonic and 28 million
biofilm 50 nt strand-specific sequence reads mappable to the C. albicans
genome.
Identification of Novel Transcriptionally Active Regions in Biofilms
nTARs were identified using MochiView. A previously published transcript
annotation (Tuch et al., 2010) was used as a starting scaffold, and additional
transcribed regions were identified. This approach identified 783 biofilm
nTARs distinct from those in the previous annotation (Extended Experimental
Procedures and Table S4A).
Differential Expression Analysis of RNA-Seq Data
For every transcribed region in our expanded biofilm genome annotation,
mean per nucleotide sequence coverage was extracted from both biofilm
and planktonic data sets and transformed into pseudo-RPKM values, and
transcripts differentially expressed between the two data sets were deter-
mined as described in Extended Experimental Procedures. The union of the
RNA-seq andmicroarray data sets was used to determine the final set of differ-
entially expressed genes (Tables S4B and S4C). Statistical significance
(p values) for the association of binding and differential transcription was
calculated using a two-tailed Fisher’s exact test.
Association of Transcription Regulator Binding Sites with Adjacent
Transcripts
To determine the association between transcription regulator binding
and differential gene expression, the binding peaks identified by ChIP-
chip were mapped to immediately adjacent, divergently transcribed genes.
A transcription regulator binding site was considered to be associated
with differential expression if at least one divergent flanking transcript
was differentially expressed in either the microarray or the RNA-seq
comparison.
Exploring Orthology Relationships and Defining Gene Age
Categories
Orthologs of theC. albicans andS. cerevisiae biofilm regulators and their direct
targets were identified using freely available orthology mapping programs and
by hand annotation using gene trees (See Extended Experimental Proce-
dures). C. albicans gene age categories were defined as follows: ‘‘old’’ are
members of gene families found in all Ascomycetes, ‘‘middle-aged’’ are
members of gene families that arose after the divergence of Schizosaccharo-
myces pombe and Schizosaccharomyces japonicus but before the divergence
of the CTG clade, and ‘‘young’’ are found only in CTG clade species. Overlap of
age categories with biofilm-induced genes is described by the hypergeometric
distribution (Extended Experimental Procedures).
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